The developing world is awash in substandard, degraded or falsified medications, which can either directly harm users or deprive them of needed treatment, researchers said.
With internet sales of medications on the rise, people everywhere are increasingly at risk, they said.
"People who do not have access to the best-quality medicines also do not have as many resources to buy the analytical instrumentation to detect the quality problems," said Marya Lieberman from University of Notre Dame in the US.
"Instead of a USD 30,000 instrument, we have developed a USD 1 paper card. We designed the card so it would be as easy and inexpensive to use as possible," said Lieberman.
Identifying poor-quality medications is challenging, as inspectors may not know in advance what chemical adulterants or degradation products they need to look for, they said.
Bad-quality medications may also contain at least some of the active ingredient, so simply detecting the presence of the real medication is not enough to rule out issues.
Lieberman and Sarah Bliese from Hamline University in the US developed a card to detect falsified or degraded antibiotics such as ciprofloxacin or ceftriaxone, both of which the World Health Organisation lists as "essential."
Each lane contained a different set of reagents to detect materials or functional groups found in active pharmaceutical ingredients, degradation products or common fillers.
To run a sample, researchers crushed a pill and rub the resulting powder across all 12 lanes, and then dipped the bottom of the paper card in water for three minutes.
The water wicks up the lanes, bringing reagents into contact with the powder. Colours are formed when the reagents interact with the pharmaceutical, filler or degradation product.
Ceftriaxone is sensitive to heat and breaks down if storage temperatures climb too high. As an experiment, researchers subjected ceftriaxone to high temperatures and ran the card test, simultaneously analysing the degradation products via liquid chromatography-mass spectrometry.
They verified that the colourimetric pattern for the degraded antibiotic was different from that of the correctly stored product.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
